# A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers

> **NCT02446301** · PHASE1 · COMPLETED · sponsor: **Lumosa Therapeutics Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Pain
- Analgesia Disorder

## Interventions

- **DRUG:** Bain®
- **DRUG:** SDE

## Key facts

- **NCT ID:** NCT02446301
- **Lead sponsor:** Lumosa Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446301, "A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02446301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*